1.06  0 (0%)		07-31 16:00
Open: 1.04 High: 1.11 Volume: 114,699		Pre. Close: 1.06 Low: 0.98 Market Cap: 0(M)

Short term
Mid term
Targets	6-month :	2.76	1-year :	3.85
Resists	First :	2.37	Second :	3.29
Pivot price	1.62
Supports	First :	0.86	Second :	0.72
MAs	MA(5) :	1.07	MA(20) :	1.85
	MA(100) :	10.55	MA(250) :	251.65
MACD	MACD :	-1.1	Signal :	-1.2
%K %D	K(14,3) :	10.3	D(3) :	9.9
RSI	RSI(14): 25.2
52-week	High :	1297.5	Low :	0.86

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ PFSA ] has closed above bottom band by 15.5%. Bollinger Bands are 85.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 107 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	1.11 - 1.12	1.12 - 1.12
Low:	0.96 - 0.97	0.97 - 0.98
Close:	1.05 - 1.06	1.06 - 1.07

Profusa, Inc. is a pioneering health technology firm that engineers advanced, bio-integrated sensors. These innovative devices, exemplified by their Lumee™ Oxygen Platform, are designed for uninterrupted observation of internal physiological markers. By leveraging artificial intelligence, Profusa translates this constant stream of data into actionable health insights, primarily to empower individuals and clinicians in the management of persistent health challenges like diabetes and critical limb ischemia.

Fri, 31 Jul 2026
PFSA | Profusa, Inc. Common Stock Insider Trading - Quiver Quantitative

Thu, 30 Jul 2026
HRT Financial discloses 82,561 Profusa (PFSA) common shares stake - stocktitan.net

Thu, 30 Jul 2026
HRT Financial boosts Profusa, Inc. (PFSA) stake with stock purchase - stocktitan.net

Mon, 27 Jul 2026
Why Is Profusa Stock Falling Monday? - benzinga.com

Mon, 27 Jul 2026
Profusa Names Jack Stover CEO; Ben Hwang Becomes President - stocktitan.net

Thu, 02 Jul 2026
Profusa to cut shares 25-to-1 before Nasdaq trading opens July 7 - stocktitan.net

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	1 (M)
Shares Float	0 (M)
Held by Insiders	1 (%)
Held by Institutions	0.5 (%)
Shares Short	53 (K)
Shares Short P.Month	5 (K)

EPS	-384.08
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-296.2
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-923.2 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	-18 (M)
Levered Free Cash Flow	-14 (M)

PE Ratio	-0.01
PEG Ratio	0
Price to Book value	-0.01
Price to Sales	0
Price to Cash Flow	-0.04

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.